Crossmark

In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy

Crossref DOI link: https://doi.org/10.1039/C6NR00294C

Published Online: 2016

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Araújo, F.

Shrestha, N.

Gomes, M. J.

Herranz-Blanco, B.

Liu, D.

Hirvonen, J. J.

Granja, P. L.

Santos, H. A.

Sarmento, B.
Funding

Funding for this research was provided by:

Seventh Framework Programme (310892)

Fundação para a Ciência e a Tecnologia (SFRH/BD/87016/2012 and SFRH/BD/90404/2012)
More Information

CROSSCHECK

: This document is CrossCheck deposited

IDENTIFIERS

: D. Liu (ResearcherID)

: P. L. Granja (ResearcherID)

COPYRIGHT AND LICENSING

: The Royal Society of Chemistry has an exclusive publication licence for this journal

OPEN ACCESS: This article is freely available. This article is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported Licence (CC BY-NC 3.0)

PUBLICATION HISTORY

: Received 12 January 2016; Accepted 19 April 2016; Accepted Manuscript published 20 April 2016; Advance Article published 6 May 2016; Version of Record published 19 May 2016

Document is current

Any future updates will be listed below